Skip to main content

Script Lift Study (SLS) Insights report overview

Dive into SLS concepts and requirements, and learn how the report can help you evaluate pre- and post-campaign prescription trends and more.

Team IQM avatar
Written by Team IQM
Updated over 2 weeks ago

On this page:

SLS Insights report overview

Script Lift Study (SLS) Insights are on-demand reports that include key details about prescribing behaviors and how they may be influenced by current and previous healthcare campaigns. Uncover pre-and post-campaign comparison data, prescription trends (Rx, TRx) for exposed and unexposed NPIs, and Rx and TRx volumes for competitor brands over the same time period. With these insights, you can compliantly assess and optimize your campaigns’ targeting strategies.

SLS Insights reports are powered by PurpleLab, who specializes in providing prescription start, switch, and refill data for NPIs. IQM combines this data with key campaign details to help you evaluate the effectiveness of your healthcare campaigns based on pre- and post-campaign prescription (Rx/TRx) volumes and competitors’ prescription patterns.

SLS Insights reports include your choice of up to three report types:

Pre vs Post overview

Determine whether campaigns influenced prescription start and refill volumes. Pre-campaign insights are based on your choice of one to six months of baseline prescription data gathered from electronic health records (EHRs) and claims databases. During-campaign and post-campaign insights are based on NRx, TRx, and exposed-NPI data retrieved by PurpleLab.

This report’s key data includes total prescription volumes, healthcare provider segmentation by speciality and location, and prescription trends for brand name versus generic prescriptions. We recommend generating a Pre vs Post report one month after a campaign ends to gauge its impact on prescription volumes.

Refer to Report metrics for a comprehensive list of the Pre vs Post data that’s available via an SLS Insights report, and review Report methods for more information on how this report is generated.

Exposed vs Unexposed overview

Evaluate a test group of exposed NPIs against a control group of unexposed NPIs to identify awareness and engagement patterns. Data is collected over the same time frame as the campaign(s) to allow for comparison and analysis.

This report’s key data includes post-intervention prescription volumes, providing insights into the campaign(s)’ impact on healthcare professionals’ prescribing patterns.

Refer to Report metrics for a comprehensive list of the Exposed vs Unexposed data that’s available via an SLS Insights report, and review Report methods for more information on how this report is generated.

Competitive Analysis overview

Compare competitors’ prescription patterns against your own across the same time frame to measure the effectiveness of your marketing strategy. Target National Drug Codes (NDCs) and key competitors are identified to establish benchmarks, then prescription data is collected pre- and post-campaign to measure prescription volumes.

This report’s key data includes comparative analyses to track competitors’ NDC trends during the same time period to measure the effectiveness of your marketing strategy versus that of your competitors.

Refer to Report metrics for a comprehensive list of the Competitive Analysis data that’s available via an SLS Insights report, and review Report methods for more information on how this report is generated.

SLS Insights report eligibility requirements

If you’re a healthcare advertiser, you may be eligible to generate an SLS Insights report. A campaign must also meet each of these conditions before it becomes eligible for SLS Insights reporting.

Requirement type

Requirement details

Campaign vertical

Healthcare*

Campaign status

Running

Expired (within the past two years)

Paused

Campaign impressions

>1 impression

Campaign duration

7 or more days

Campaign start date

[Release date], 2025 or later (or earlier upon request from IQM’s support team)

Audience type**

Matched audience created from NPI IDs

* Healthcare: Any campaign created under a healthcare advertiser account is a “Healthcare” campaign.

** Audience type: The campaign must only include the audience type listed in this requirements table. For example, you won’t be able to generate an SLS Insights report for a campaign if it includes a matched audience created from NPI IDs and a retargeted audience consisting of your website’s past visitors. The NPI-based audience must be assigned to the campaign at the time of report creation and while report generation is in progress to remain eligible.

SLS Insights report pricing

There is a cost associated with generating an SLS Insights report. You can reference its price after you enter key details—like the campaign’s total number of impressions and date range—and before you generate the report. We calculate these impressions on a CPM basis.

Refer to Generate or manage a Script Lift Study (SLS) Insights report for more information on where to reference the report-price preview.

Price deduction - Sufficient funds

The workflow to generate an SLS Insights report ends with a Generate button that you’ll use to create the report. We’ll deduct the SLS Cost from your account’s available balance once the report successfully generates. In most cases, this will take place immediately after you select Generate in the Generate Script Lift Study widget.

Refer to Generate or manage a Script Lift Study (SLS) Insights report for step-by-step instructions on creating a new report.

Price deduction - Insufficient funds

Funds notice: Organization administrators can add funds to an account. Contact yours to complete this process.

The workflow to create an SLS Insights report ends with a Generate button that you can use to create the report. If your account’s available balance is less than the SLS Cost, then this button will prompt you to add funds to your account instead. We’ll redirect you to enter a fund amount and select a payment method when you click Add Funds.

Note that you’ll need to refresh the Generate Script Lift Study widget to reflect your account’s updated balance and continue with report generation.

Pricing for SLS Insights reports with overlapping datasets

There may be instances when you generate multiple SLS Insights reports with partially overlapping date ranges for the same campaign. This means that the insight data also overlaps. You’ll pay only once for SLS Insights data for each date—regardless of the report type(s) you select.

Example: An advertiser generates two reports for the same campaign—one with a date range of August 1st-10th, and another with a date range of August 5th-20th. Since they already paid for the insights from August 1st-10th, we’ll only change them for a portion of the second report: the new data generated for the August 11th-20th date range. We’ll still aggregate data from the full August 5th-20th date range in the second report.

The same pricing logic would still apply if the advertiser generated the first report for the Pre vs Post report type, and the second report for the Pre vs Post and NPI Exposure report types. The Chargeable Impressions and SLS Cost fields are calculated based on the selected campaign(s)’ impressions and Study Duration rather than by report type.

Note that each report’s end date will reflect the latest campaign End Date or today’s date minus 14 days—whichever took place first. We recommend generating an SLS Insights report 14 days following the campaign’s End Date if you’d like to generate insights that span the entire campaign duration.

SLS Insights report metrics

More healthcare campaign insights: Practitioner Level Data (PLD) Insights reports are another resource for healthcare campaign data. They include key details about healthcare professionals that you targeted in current and prior campaigns, including ad-exposure and engagement data, demographic data, and physician-specialty data for your healthcare audiences. Refer to PLD Insights report overview for more details, including eligibility requirements and included metrics.

The SLS Insights report includes NRx, TRx, and NPI Reach analyses broken out by a particular dimension, such as geographic location or medical specialty.

Review the SLS Insights report metrics below, and refer to Generate or manage a Script Lift Study (SLS) Insights report when you’re ready to create one.

Study Information

Review the inputs you selected during report creation, which dictate the information that’s included in the generated report.

Study Information includes the following details:

  • Study ID

  • Study Name

  • Study Type (Report Type)

  • Advertiser Name

  • IO ID

  • IO Name

  • Campaign Duration

  • Drug Name

  • Competitor

  • Concept Group IDs

  • Total NRx

  • Total TRx

  • Total Impressions

  • Campaign Spend

  • NPIs Reached

  • Campaign(s)

Specialization

Assess a breakdown of specialties by percentage to determine which ones your campaign reached; and review those specialties’ NPI Reach, total-prescription volume, and new-prescription volume.

Specialization includes the following metrics:

  • Speciality

  • NPI Reach

  • TRx

  • NRx

TRx vs NRx by Speciality

Compare total-prescription and new-prescription volumes by specialty; and review those specialties’ NPI Reach, total-prescription volume, and new-prescription volume in a table format.

TRx vs NRX by Specialty includes the following metrics:

  • Specialization

  • NPI Reach

  • TRx

  • NRx

NPI Reach by State

Determine the total percentage and absolute value of NPIs reached through the selected campaigns at the state level. For example, if 5K total NPIs were reached, and New York displays a 20% NPI Reach by State in the report, then a total of 1K NPIs were reached in New York.

You can also review these states’ NPI Reach, total-prescription volume, and new-prescription volume.

NPI Reach by State includes the following metrics:

  • Location (States)

  • NPI Reach

  • NRx

  • TRx

Prescription Behavior (Pre vs Post)

Review the total percentage and absolute number of NPIs reached who prescribed the same drug during a given week Pre- and Post Campaign; and determine NPI Reach, total-prescription volume, and new-prescription volume.

Prescription Behavior (Pre vs Post) includes the following metrics:

  • Date

  • Campaign Stage (Pre Campaign, Post Campaign)

  • NPI Reach

  • TRx

  • NRx

Prescription Behavior (Exposed vs Unexposed NPI)

Assess how many, and what percentage of, NPIs were exposed to the campaign and whether total-prescription and new-prescription volumes correlate to that exposure.

The report also breaks out NPI exposure, total-prescription volume, and new-prescription volume by Campaign Stage.

Prescription Behavior (Exposed vs Unexposed NPI) includes the following metrics:

  • Date

  • Campaign Stage (Pre Campaign, Post Campaign)

  • Exposed NPI (%, #)

  • Unexposed NPI (%, #)

  • TRx

  • NRx

Prescription Behavior (Competitive Analysis)

Compare total-prescription and new-prescription volumes for up to three competitor brands. This comparison includes these competitor brands’ average total and average new prescriptions per NPI, as well as NPI Reach details.

Prescription Behavior (Competitive Analysis) includes the following metrics:

  • NPI Reach by date and brand

  • TRx by date and brand

  • NRx by date and brand

  • Date

  • Average TRx per NPI

  • Average NRx per NPI

  • NPI per medication

Performance (by Platform, by Creative, by Channel)

Discover and compare total-prescription and new-prescription volumes by dimension. These insights signal which platforms, creatives, and channels to invest in to achieve your marketing strategy goals.

Prescription Behavior (Exposed vs Unexposed NPI) includes the following metrics:

  • Dimension (Platform, Creative, Channel)

  • NPI Reach

  • TRx

  • NRx

SLS Insights reporting methods

Review the processes below to learn how healthcare campaign data is transformed into SLS insights.

Pre vs Post Analysis

  1. You run a healthcare campaign in the IQM platform, and target an NPI-based Matched audience.

  2. When you generate an SLS Insights report and choose the Pre vs Post report type, IQM generates NPI reach data based on the campaign duration and the Lookback Duration you select.

  3. IQM shares the concept group ID, campaign duration, and Lookback Duration with PurpleLab.

  4. PurpleLab retrieves NRx, TRx, and exposed-NPI data.

  5. IQM generates a report that matches PurpleLab’s data with your campaign’s data to surface key insights. These insights relate to pre-campaign-exposure and post-campaign-exposure NRx and TRx volumes.

  6. You review the Pre vs Post Analysis data insights featured in your SLS Insights report, and apply them to current and future healthcare campaigns.

Exposed vs Unexposed Analysis

  1. You run a healthcare campaign in the IQM platform, and target an NPI-based Matched audience.

  2. When you generate an SLS Insights report and choose the Exposed vs Unexposed report type, IQM generates NPI reach data based on the campaign duration and the Lookback Duration you select.

  3. IQM shares the Concept Group ID and the campaigns’ Study Duration details with PurpleLab.

  4. PurpleLab retrieves NRx and TRx volumes for specific NDCs across the pre-campaign Lookback Duration. PurpleLab also retrieves a list of all NPIs that have prescribed those NDCs.

  5. IQM generates a report that matches PurpleLab’s data with your campaign’s data to surface key insights. These insights relate to NPI exposure and NRx and TRx volumes. IQM also generates an NPI test group and NPI control group for further analysis.

    1. The NPI test group includes NRx and TRx volumes for exposed NPIs.

    2. The NPI control group includes NRx and TRx volumes for unexposed NPIs.

  6. You review the Exposed vs Unexposed Analysis data featured in your SLS Insights report to assess prescription volume patterns in the test and control group, and apply these insights to current and future healthcare campaigns.

Competitive Analysis

  1. You run a healthcare campaign in the IQM platform, and target an NPI-based Matched audience.

  2. When you generate an SLS Insights report and choose the Competitive Analysis report type, IQM generates NPI reach data based on the campaign duration and the Lookback Duration you select.

  3. IQM shares the Concept Group ID, campaign duration, and Lookback Duration with PurpleLab, along with the National Drug Codes (NDC) for up to three competitor brands that you indicated in the report.

  4. PurpleLab retrieves NRx and TRx data for the NPI-based Matched audience and competitor NDCs.

  5. IQM generates a report that provides insights into NRx and TRx volumes for each competitor brand, and compares those values to your brand’s NRx and TRx volumes over the same time frame.

  6. You review the Competitive Analysis data insights featured in your SLS Insights report, and apply them to current and future healthcare campaigns.

SLS Insights report statuses

You can review an SLS Insights report’s current status on the Script Lift Study page.

Status

Definition

Ready

Your insights are generated. You can view, download, or email the SLS Insights report.

Processing

We’re working on generating your insights. Check back in about 15 minutes.

Failed*

You either encountered a technical error during report generation, or the campaign you selected is no longer eligible for SLS Insights reporting. Try again in a few minutes to rule out a technical error.

* If an SLS Insights report features a Failed status, no SLS Cost will be deducted from the advertiser account’s balance.

Key terms and concepts

Lookback Duration and Study Duration

Before you generate an SLS Insights report, you’ll need to choose a Lookback Duration. The Lookback Duration ranges from 1 to 6 months, and is the period of time that precedes the selected campaigns’ earliest Start Date. It helps measure whether prescription volumes increased during or after the campaign.

Study Duration represents the total time period that’s analyzed for SLS insights, including both the campaign’s active time frame and the Lookback Duration you chose.

Locate additional SLS Insights report resources

Did this answer your question?